Replies to post #10769 on Momenta Pharmaceuticals, Inc. (MNTA)

[Rocky3]

What price do you think MNTA would be at now if their percentage share of Lovenox revenues didn't change upon Amphastar/Watson's entry into the market? I would say that the price would be well into the $20s.

We disagree. MNTA would still be losing money, even with the original deal. I doubt that it would be in the 20s. Value will be driven by mCop approval (and hopefully eventually by the Baxter deal).